Washington, D.C. 20549

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

		Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP
		850 Winter Street
Intersouth Partners		Waltham, MA
406 Blackwell Street, Suite 200		Attn: Jay K. Hachigan, Esq.
Durham, NC 27701-3984		(781) 890-8800

(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)

(Date of Event Which Requires Filing of this Statement)

 

 

CUSIP No.		016259103

CUSIP No.		016259103

CUSIP No.		016259103

CUSIP No.		016259103

CUSIP No.		016259103

SCHEDULE 13D

Item 1. Security and Issuer.

This statement on Schedule 13D relates to the Common Stock, $.01 par value per share (the “Common Stock”), of Alimera Sciences, Inc. (the “Issuer”). The Issuer’s principal executive office is located at 6120 Windward Parkway, Suite 290, Alpharetta, Georgia 30005.

Item 2. Identity and Background.

(a) This Schedule 13D is being filed on behalf of each of the following persons pursuant to Rule 13d-1(k) of Regulation D-G under the Securities Exchange Act of 1934, as amended (the “Exchange Act”): Intersouth Partners V, L.P. (“IP V”), Intersouth Affiliates V, L.P. (“IA V”), Intersouth Partners VI, L.P. (“IP VI”), and Intersouth Partners VII, L.P. (“IP VII” and together with IP V, IA V and IP VI, the “Reporting Persons”). The Reporting Persons are making this single, joint filing because they may be deemed to constitute a “group” within the meaning of Section 13(d)(3) of the Exchange Act. The agreement between the Reporting Persons to file as a group (the “Joint Filing Agreement”) is attached hereto as Exhibit A.

(b)-(c) The principal business of each of IP V, IA V, IP VI and IP VII is that of a private investment partnership. The sole general partner of IP V and IA V is Intersouth Associates V, LLC (“IA V, LLC”). The principal business of IA V, LLC is that of acting as the general partner of IP V and IA V. Mitch Mumma and Dennis Dougherty are the member managers of IA V, LLC. The sole general partner of IP VI is Intersouth Associates VI, LLC (“IA VI, LLC”). The principal business of IA VI, LLC is that of acting as the general partner of IP VI. Mitch Mumma and Dennis Dougherty are the member managers of IA VI, LLC. The sole general partner of IP VII is Intersouth Associates VII, LLC (“IA VII, LLC”). The principal business of IA VII, LLC is that of acting as the general partner of IP VII. Mitch Mumma and Dennis Dougherty are the member managers of IA VI, LLC.

The principal business address of each of the entities and individuals named in this Item 2 is c/o Intersouth Partners, 406 Blackwell Street, Suite 200, Durham, North Carolina 02771-3984.

(d)-(e) During the last five years, none of the Reporting Persons or individuals named in this Item 2 has (i) has been convicted in any criminal proceeding (excluding traffic violations or similar misdemeanors); or (ii) been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction resulting in his being subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Each of the individuals named in this Item 2 is a citizen of the United States.

CUSIP No.		016259103

Item 3. Source and Amount of Funds or Other Consideration.

On April 21, 2010, the Registration Statement on Form S-1 filed with the Securities and Exchange Commission by the Issuer (File No. 333-162782) in connection with its initial public offering of 6,550,000 shares of Common Stock was declared effective. The closing of the offering took place on April 27, 2010, and at such closing IP V purchased 86,394 shares of Common Stock, IA V purchased 3,974 shares of Common Stock, IP VI purchased 90,909 shares of Common Stock and IP VII purchased 196,210 shares of Common Stock at the initial public offering price of $11.00 per share. The source of funds for such purchase was the working capital of IP V, IA V, IP VI and IP VII, respectively.

Item 4. Purpose of Transaction.

Each of IP V, IA V, IP VI and IP VII purchased additional Common Stock of the Issuer for investment purposes. Philip Tracy, a director of the Issuer, holds certain voting powers with respect to the reportable securities owned by IP V, IA V, IP VI and IP VII, but except as otherwise described in this statement, the Reporting Persons do not have any present plans or proposals that relate to or would result in: (i) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (ii) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (iii) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (iv) any change in the present board of directors or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the board; (v) any material change in the present capitalization or dividend policy of the Issuer; (vi) any other material change in the Issuer’s business or corporate structure; (vii) changes in the Issuer’s charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (viii) causing a class of securities of the Issuer to be de-listed from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (ix) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (x) any action similar to any of those enumerated above.

Item 5. Interest in Securities of the Issuer.

The information below is based on a total of 31,051,055 shares of Common Stock outstanding as of the date of the event which requires the filing of this statement.

(a) IP V directly beneficially owns 1,605,743 shares of Common Stock, or approximately 5.2% of the Common Stock outstanding. IA V directly beneficially owns 73,590 shares of Common Stock, or approximately 0.2% of the Common Stock outstanding. IP VI directly beneficially owns 2,053,381 shares of Common Stock, or approximately 6.6% of the Common Stock outstanding. IP VII directly beneficially owns 1,144,766 shares of Common Stock, or approximately 3.7% of the Common Stock outstanding. IA V, LLC, as the general partner of IP V and IA V, may be deemed to indirectly beneficially own the securities owned by IP V and IA V. IA VI, LLC, as the general partner of IP VI, may be deemed to indirectly beneficially own the securities owned by IP VI. IA VII, LLC, as the general partner of IP VII, may be deemed to indirectly beneficially own the securities owned by IP VII.

CUSIP No.		016259103

(b) Each of (i) the managing members of IA V, LLC, IA VI, LLC and (ii) IA VII, LLC and Philip Tracy may be deemed to share the power to vote or direct the voting of and to dispose or direct the disposition of the securities of the Issuer that are beneficially owned by IP V, IA V, IP VI and IP VII. Each such person disclaims beneficial ownership of all securities other than those he or she owns directly, if any, or by virtue of his or her indirect pro rata interest, as a member of IA V, LLC, IA VI, LLC and IA VII, LLC, in the securities owned by IP V, IA V, IP VI and IP VII.

(c) Prior to the effectiveness of the Issuer’s initial public offering, the Issuer effected a 3.4 to 1 reverse split of the Common Stock. Upon closing of the initial public offering, all shares of the Issuer’s outstanding series of Preferred Stock were converted to Common Stock on a 1-for-1 basis. Except as described in this statement, none of the Reporting Persons has effected any transactions in the Common Stock in the 60 days prior to the date of this statement.

(d) Except as described in this statement, no person has the power to direct the receipt of dividends on or the proceeds of sales of, the shares of Common Stock owned by the Reporting Persons.

(e) Not applicable.

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Each of IP V, IA V, IP VI and IP VII is a party to that certain Second Amended and Restated Investor Rights Agreement, dated March 17, 2008, (the “Investor Rights Agreement”), which is attached as an exhibit to the Issuer’s Amendment No. 1 to Form S-1 filed on December 23, 2009 and incorporated by reference herein. Effective as of the consummation of the Issuer’s public offering, Section 3, Section 4 (other than Section 4.1(m)) and Section 5 of the Investor Rights Agreement were terminated. Pursuant to the Investor Rights Agreement, each of IP V, IA V, IP VI and IP VII (a) has certain registration rights with respect to its Common Stock, (b) is subject to certain restrictions on the sale of its Common Stock.

Item 7. Material to be Filed as Exhibits.

Exhibit A — Joint Filing Agreement (appears at page 8 of this statement)

CUSIP No.		016259103

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

CUSIP No.		016259103

Exhibit A

AGREEMENT REGARDING THE JOINT FILING OF
SCHEDULE 13D

The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.